monday.com stock bounces premarket after sliding to a 52-week low — here’s what’s driving MNDY
15 January 2026
1 min read

monday.com stock bounces premarket after sliding to a 52-week low — here’s what’s driving MNDY

New York, January 15, 2026, 07:53 EST — Premarket

  • monday.com shares climbed roughly 1% in premarket trading, rebounding from a 6.4% slide the day before.
  • Jefferies stuck with its Buy rating, pointing out that the stock’s valuation has tightened compared to its software peers.
  • Investors are gearing up for the company’s upcoming earnings report and its initial outlook for 2026.

Shares of monday.com Ltd edged up 0.9% in premarket trading on Thursday, reaching $131.50. The work-management software company had dropped 6.4% in the prior session, closing at $130.33. 1

On Wednesday, the stock tumbled to an intraday low of $129.99, marking its lowest point in 52 weeks, before stabilizing near the close. The selloff was steep, and now all eyes are on whether dip-buyers step in with enough volume following a week of declines.

Jefferies stuck with its Buy rating and maintained a $260 price target, highlighting a sharp valuation reset following the stock’s drop. The firm noted the stock is trading near 3.5 times enterprise value to sales — a typical metric for software companies comparing firm value (adjusted for cash and debt) against revenue. Jefferies also said it expects the company’s initial fiscal 2026 revenue guidance to come in more cautiously than consensus estimates. 2

The pressure wasn’t limited to just one area. The iShares Expanded Tech-Software Sector ETF tumbled 2.2% on Wednesday. Meanwhile, Atlassian and Asana each slid over 4%, highlighting the jittery mood in growth software stocks.

monday.com has long traded like a classic growth stock: skepticism around forward guidance or pricing power can trigger sharp sell-offs. On the flip side, the stock tends to rebound quickly if there’s evidence enterprise demand remains strong and margins continue to expand.

Next on the docket: earnings timing and guidance. Nasdaq’s calendar points to a Feb. 9 report, though Investing.com expects Feb. 16. monday.com hasn’t officially announced a date on its investor site yet.

The valuation case holds only if the next outlook doesn’t rattle the market again. D.A. Davidson flagged longer sales cycles and macro uncertainty as threats to software budgets. Another round of cautious guidance could trap the stock near its lows.

The stock’s slump began after the last earnings report. In November, monday.com topped estimates but forecasted fourth-quarter revenue between $328 million and $330 million, falling short of market expectations and dampening enthusiasm.

Jefferies pointed to deal comps in the sector, highlighting last year’s Smartsheet take-private by Blackstone and Vista. That move pulled a close peer off the public market, pushing investors to rely more heavily on the remaining companies for benchmarks.

Traders will be eyeing if the premarket bounce sticks once liquidity ramps up at the open. The next major trigger is monday.com’s quarterly report, along with its initial 2026 targets. That report should reveal if this move marks a bottom or simply a breather.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Rocket Lab stock slips before the open after KeyBanc downgrade flags “balanced” risk-reward
Next Story

Rocket Lab stock slips before the open after KeyBanc downgrade flags “balanced” risk-reward

Go toTop